Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $246,822 - $297,946
918 Added 6.79%
14,434 $4.1 Million
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $430,854 - $486,055
1,685 Added 14.24%
13,516 $3.89 Million
Q3 2023

Nov 03, 2023

BUY
$218.65 - $271.46 $263,691 - $327,380
1,206 Added 11.35%
11,831 $3.18 Million
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $140,989 - $166,717
658 Added 6.6%
10,625 $2.36 Million
Q1 2023

May 01, 2023

BUY
$225.79 - $275.2 $79,026 - $96,320
350 Added 3.64%
9,967 $2.41 Million
Q4 2022

Feb 07, 2023

BUY
$229.03 - $291.01 $257,658 - $327,386
1,125 Added 13.25%
9,617 $2.53 Million
Q3 2022

Nov 03, 2022

BUY
$224.46 - $253.15 $92,028 - $103,791
410 Added 5.07%
8,492 $1.91 Million
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $93,437 - $103,979
-405 Reduced 4.77%
8,082 $1.97 Million
Q1 2022

May 09, 2022

BUY
$219.27 - $242.57 $1,096 - $1,212
5 Added 0.06%
8,487 $2.05 Million
Q4 2021

Jan 26, 2022

SELL
$198.88 - $227.6 $156,120 - $178,666
-785 Reduced 8.47%
8,482 $1.91 Million
Q3 2021

Nov 05, 2021

SELL
$212.27 - $248.7 $125,663 - $147,230
-592 Reduced 6.0%
9,267 $1.97 Million
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $135,709 - $150,560
-581 Reduced 5.57%
9,859 $2.4 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $121,384 - $141,454
547 Added 5.53%
10,440 $2.6 Million
Q4 2020

Feb 05, 2021

BUY
$216.38 - $257.67 $206,859 - $246,332
956 Added 10.7%
9,893 $2.27 Million
Q3 2020

Nov 09, 2020

BUY
$234.65 - $260.95 $55,612 - $61,845
237 Added 2.72%
8,937 $2.27 Million
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $201,568 - $247,352
1,019 Added 13.27%
8,700 $2.05 Million
Q1 2020

Apr 24, 2020

SELL
$182.24 - $241.7 $130,301 - $172,815
-715 Reduced 8.52%
7,681 $1.56 Million
Q4 2019

Feb 07, 2020

BUY
$189.21 - $243.2 $247,865 - $318,592
1,310 Added 18.49%
8,396 $2.02 Million
Q3 2019

Nov 06, 2019

BUY
$174.11 - $208.62 $100,635 - $120,582
578 Added 8.88%
7,086 $1.37 Million
Q2 2019

Aug 06, 2019

BUY
$166.7 - $195.41 $53,177 - $62,335
319 Added 5.15%
6,508 $1.2 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $13,926 - $15,698
-77 Reduced 1.23%
6,189 $1.18 Million
Q4 2018

Feb 08, 2019

BUY
$178.4 - $208.25 $31,398 - $36,652
176 Added 2.89%
6,266 $1.22 Million
Q3 2018

Nov 06, 2018

BUY
$185.29 - $208.89 $21,123 - $23,813
114 Added 1.91%
6,090 $1.26 Million
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $29,224 - $32,825
176 Added 3.03%
5,976 $1.1 Million
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $24,059 - $28,116
142 Added 2.51%
5,800 $988,000
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $479,701 - $535,972
2,842 Added 100.92%
5,658 $984,000
Q3 2017

Oct 31, 2017

SELL
$167.29 - $191.0 $50,019 - $57,109
-299 Reduced 9.6%
2,816 $525,000
Q2 2017

Aug 07, 2017

BUY
N/A
3,115
3,115 $537,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Lincoln National Corp Portfolio

Follow Lincoln National Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Lincoln National Corp with notifications on news.